- Home
- VMAR vs KZIA Comparison
VMAR vs KZIA Comparison
Compare VMAR & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- KZIA
- Stock Information
- Founded
- VMAR 1995
- KZIA 1994
- Country
- VMAR Canada
- KZIA Australia
- Employees
- VMAR N/A
- KZIA N/A
- Industry
- VMAR Marine Transportation
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- KZIA Health Care
- Exchange
- VMAR Nasdaq
- KZIA Nasdaq
- Market Cap
- VMAR 5.1M
- KZIA 5.1M
- IPO Year
- VMAR 2020
- KZIA 1999
- Fundamental
- Price
- VMAR $6.60
- KZIA $9.82
- Analyst Decision
- VMAR Strong Buy
- KZIA Strong Buy
- Analyst Count
- VMAR 1
- KZIA 2
- Target Price
- VMAR $2,700.00
- KZIA $14.00
- AVG Volume (30 Days)
- VMAR 39.6K
- KZIA 656.0K
- Earning Date
- VMAR 07-11-2025
- KZIA 08-05-2025
- Dividend Yield
- VMAR N/A
- KZIA N/A
- EPS Growth
- VMAR N/A
- KZIA N/A
- EPS
- VMAR N/A
- KZIA N/A
- Revenue
- VMAR $1,128,568.00
- KZIA $1,549,158.00
- Revenue This Year
- VMAR N/A
- KZIA N/A
- Revenue Next Year
- VMAR $264.29
- KZIA N/A
- P/E Ratio
- VMAR N/A
- KZIA N/A
- Revenue Growth
- VMAR N/A
- KZIA 248983.08
- 52 Week Low
- VMAR $4.04
- KZIA $2.86
- 52 Week High
- VMAR $675.00
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- VMAR 48.62
- KZIA 58.07
- Support Level
- VMAR $5.74
- KZIA $8.66
- Resistance Level
- VMAR $6.28
- KZIA $10.37
- Average True Range (ATR)
- VMAR 0.34
- KZIA 1.26
- MACD
- VMAR 0.06
- KZIA -0.08
- Stochastic Oscillator
- VMAR 68.98
- KZIA 64.50
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.